Evidence-based practice of photopheresis 1987-2001: A report of a workshop of the British Photodermatology Group and the U.K. Skin Lymphoma Group

British Journal of Dermatology

Volumn 154, Issue 1, 2006, Pages 7-20

  McKenna, K E ^a   Whittaker, S ^b   Rhodes, L E ^c   Taylor, P ^d   Lloyd, J ^e   Ibbotson, S ^f   Russell Jones, R ^b  

^a BELFAST CITY HOSPITAL   (United Kingdom)

^b GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d ROTHERHAM GENERAL HOSPITAL   (United Kingdom)

^e Regional Medical Physics Department   (United Kingdom)

^f NINEWELLS HOSPITAL   (United Kingdom)

Author keywords

Cardiac transplant rejection; Cutaneous T cell lymphoma; Extracorporeal photochemotherapy; Graft versus host disease; S zary syndrome

Indexed keywords

AZATHIOPRINE; CHLORMETHINE; CORTICOSTEROID; CYCLOSPORIN A; ETRETINATE; METHOTREXATE; METHOXSALEN; OKT 3; PENICILLAMINE; PREDNISOLONE; PSORALEN; RECOMBINANT ALPHA INTERFERON; STEROID; THALIDOMIDE;

ANEMIA; APOPTOSIS; ATOPIC DERMATITIS; BURN; CARDIAC GRAFT REJECTION; CHEMOTHERAPY INDUCED EMESIS; CHRONIC GRAFT REJECTION; CLINICAL TRIAL; CONFERENCE PAPER; CUTANEOUS T CELL LYMPHOMA; DERMATOMYOSITIS; DIARRHEA; DISCOID LUPUS ERYTHEMATOSUS; DRUG FEVER; ELECTRON THERAPY; EPIDERMOLYSIS BULLOSA ACQUISITA; ERYTHEMA; ERYTHRODERMA; EVIDENCE BASED PRACTICE; GRAFT VERSUS HOST REACTION; HEALTH SERVICE; HEPATITIS C; HUMAN; HYPOTENSION; INDUCED HYPOTENSION; INSULIN DEPENDENT DIABETES MELLITUS; IRRADIATION; KIDNEY ALLOGRAFT REJECTION; LICHEN PLANUS; LITERATURE; LUNG GRAFT REJECTION; LYME DISEASE; LYMPHOCYTE; LYMPHOCYTE DEPLETION; MEDICAL SOCIETY; MULTIPLE SCLEROSIS; NAUSEA; NONHUMAN; PEMPHIGUS; PHOTOCHEMOTHERAPY; PRIORITY JOURNAL; PSORIASIS; PSORIATIC ARTHRITIS; PUBLICATION; PUVA; RHEUMATOID ARTHRITIS; SCLERODERMA; SCLEROMYXEDEMA; SEPARATION TECHNIQUE; SEZARY SYNDROME; SKIN LYMPHOMA; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; TREATMENT OUTCOME; ULTRAVIOLET A RADIATION; UNITED KINGDOM;

COMBINED MODALITY THERAPY; EVIDENCE-BASED MEDICINE; GRAFT REJECTION; GRAFT VS HOST DISEASE; HEART TRANSPLANTATION; HUMANS; LYMPHOMA, T-CELL, CUTANEOUS; PHOTOPHERESIS; SKIN NEOPLASMS;

EID: 33644890495     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2005.06857.x     Document Type: Conference Paper

References (149)

1. Edelson RL Berger C Gasparro F et al. Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy: preliminary results N Engl J Med 1987 316 297 303
2. Smith EP Sniecinski I Dagis AC et al. Extracorporeal photochemotherapy for treatment of drug-resistant graft-vs.-host disease Biol Blood Marrow Transplant 1998 4 27 37
3. Barr ML Meiser BM Eisen HJ et al. Photopheresis for the prevention of rejection in cardiac transplantation. Photopheresis Transplantation Study Group N Engl J Med 1998 339 1744 51
4. Ludvigsson J Samuelsson U Ernerudh J et al. Photopheresis at onset of type 1 diabetes: a randomised, double blind, placebo controlled trial Arch Dis Child 2001 85 149 54
5. Horina JH Mullegger RR Horn S et al. Photopheresis for renal allograft rejection Lancet 1995 346 61
6. Rook AH Freundlich B Jegasothy BV et al. Treatment of systemic sclerosis with extracorporeal photochemotherapy Arch Dermatol 1992 128 337 46
7. Rostami AM Sater RA Bird SJ et al. A double-blind, placebo-controlled trial of extracorporeal photopheresis in chronic progressive multiple sclerosis Mult Scler 1999 5 198 203
8. Wollina U Lange D Looks A Short-time extracorporeal photochemotherapy in the treatment of drug-resistant autoimmune bullous diseases Dermatology 1999 198 140 4
9. Malawista SE Trock DH Edelson RL Treatment of rheumatoid arthritis by extracorporeal photochemotherapy Arthritis Rheum 1991 34 646 54
10. Vonderheid EC Bigler RD Rogers TJ et al. Effect of extracorporeal photopheresis on selected immunologic parameters in psoriasis vulgaris Yale J Biol Med 1989 62 653 64
11. Wilfert H Honigsmann H Steiner G et al. Treatment of psoriatic arthritis by extracorporeal photochemotherapy Br J Dermatol 1990 122 225 32
12. Prinz B Nachbar F Plewig G Treatment of severe atopic dermatitis with extracorporeal photopheresis Arch Dermatol Res 1994 287 48 52
13. Knobler RM Graninger W Graninger W et al. Extracorporeal photochemotherapy for the treatment of systemic lupus erythematosus Arthritis Rheum 1992 35 319 24
14. Richter HI Krutmann J Goerz G Extracorporeal photopheresis in therapy-refractory disseminated discoid lupus erythematosus Hautarzt 1998 49 487 91
15. Bécherel PA Bussel A Chosidow O et al. Extracorporeal photochemotherapy for chronic erosive lichen planus Lancet 1998 351 805
16. Bisaccia E Berger C Klainer AS Extracorporeal photopheresis in the treatment of AIDS-related complex: a pilot study Ann Intern Med 1990 113 270 5
17. Berkson M Lazarus GS Uberti-Benz M Rook AH Extracorporeal photochemotherapy: a potentially useful treatment for scleromyxedema J Am Acad Dermatol 1991 25 724
18. Stables GI Taylor PC Highet AS Scleredema associated with paraproteinaemia treated by extracorporeal photopheresis Br J Dermatol 2000 142 781 3
19. De Wilde A DiSpaltro FX Geller A et al. Extracorporeal photochemotherapy as adjunctive treatment in juvenile dermatomyositis: a case report Arch Dermatol 1992 128 1656 7
20. Randazzo JP DiSpaltro FX Cottrill C et al. Successful treatment of a patient with chronic Lyme arthritis with extracorporeal photochemotherapy J Am Acad Dermatol 1994 30 908 10
21. O'Brien CB Henzel BS Moonka DK et al. Extracorporeal photopheresis alone and with interferon-α2a in chronic hepatitis C patients who failed previous interferon therapy Dig Dis Sci 1999 44 1020 6
22. Wieselthier JS Rothstein TL Yu TL et al. Inefficacy of extracorporeal photochemotherapy in the treatment of B-cell chronic lymphocytic leukemia: preliminary results Am J Hematol 1992 41 123 7
23. Cox NH Eedy DJ Morton CA Guidelines for management of Bowen's disease Br J Dermatol 1999 141 633 41
24. Gratten C Powell S Humphreys F Management and diagnostic guidelines for urticaria and angio-oedema Br J Dermatol 2001 144 708 14
25. Song PS Tapley KJ Photochemistry and photobiology of psoralens Photochem Photobiol 1979 29 1177 97
26. Gasparro FP Dall'Amico R Goldminz D et al. Molecular aspects of extracorporeal photochemotherapy Yale J Biol Med 1989 62 579 93
27. Yoo EK Rook AH Elenitsas R et al. Apoptosis induction by ultraviolet light A and photochemotherapy in cutaneous T-cell lymphoma: relevance in mechanism of therapeutic action J Invest Dermatol 1996 107 235 42
28. Lee KH Garro J Engineering aspects of extracorporeal photochemistry Yale J Biol Med 1989 62 621 8
29. Edelson RL Heald PW Perez MI Berger C Extracorporeal photochemotherapy Biol Ther Cancer Updates 1994 4 1 12
30. Vowels BR Cassin M Boufal MH et al. Extracorporeal photochemotherapy induces the production of tumor necrosis factor-alpha in monocytes: implications for the treatment of cutaneous T-cell lymphoma and systemic sclerosis J Invest Dermatol 1992 98 686 92
31. Wolfe JT Lessin SR Singh AH Rook AH Review of immunomodulation by photopheresis: treatment of cutaneous T-cell lymphoma, autoimmune disease, and allograft rejection Artif Organs 1994 18 888 97
32. Di Renzo M Rubegni P De Aloe G et al. Extracorporeal photochemotherapy restores Th1/Th2 imbalance in patients with early stage cutaneous T cell lymphoma Immunology 1997 92 99 103
33. Tokura Y Seo N Yagi H et al. Treatment of T lymphocytes with 8-methoxypsoralen plus ultraviolet A induces transient but biologically active Th1 skewing cytokine production J Invest Dermatol 1999 113 202 13
34. Klosner G Trautinger F Knobler RM Neuner P Treatment of peripheral blood mononuclear cells with 8-methoxypsoralen plus ultraviolet A radiation induces a shift in cytokine expression from a Th1 to a Th2 response J Invest Dermatol 2001 116 459 62
35. Fimiani M Rubegni P Pimpinelli N et al. Extracorporeal photochemotherapy induces a significant increase in CD36+ circulating monocytes in patients with mycosis fungoides Dermatology 1997 194 107 10
36. Fadok VA Bratton DL Konowal A et al. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2 and PAF J Clin Invest 1998 101 890 8
37. Berger CL Xu A-L Hanlon D et al. Induction of tumor loaded dendritic cells Int J Cancer 2001 91 438 47
38. Albert ML Sauter B Bhardwaj N Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs Nature 1998 392 86 9
39. Timmerman JM Levy R Dendritic cell vaccines for cancer immunotherapy Annu Rev Med 1999 50 507 29
40. Berger CL Longley BJ Imaeda S et al. Tumor-specific peptides in cutaneous T-cell lymphoma: association with class I major histocompatibility complex and possible derivation from clonotypic T-cell receptor Int J Cancer 1998 76 304 11
41. Edelson RL Photopheresis: a new therapeutic concept Yale J Biol Med 1989 62 565 77
42. Christensen I Heald PW Photopheresis in the 1990s J Clin Apheresis 1991 6 216 20
43. Oliven A Shechter Y Extracorporeal photopheresis: a review Blood Rev 2001 15 103 8
44. Heald PW Perez MI Gasparro F Dosage guidelines: extracorporeal photochemotherapy (photopheresis) Arch Dermatol 1990 126 1369
45. Wagner G Hoffmann C Busch U et al. 8-MOP plasma levels in PUVA problem cases with psoriasis Br J Dermatol 1979 101 285 92
46. Schafer-Korting M Korting HC Intraindividual variations of 8-methoxypsoralen plasma levels Arch Dermatol 1982 272 1 7
47. Shephard SE Nestle FO Panizzon R Pharmacokinetics of 8-methoxypsoralen during extracorporeal photopheresis Photodermatol Photoimmunol Photomed 1999 15 64 74
48. Knobler RM Trautinger F Graninger W et al. Parenteral administration of 8-methoxypsoralen in photopheresis J Am Acad Dermatol 1993 28 580 4
49. Kraemer KH Waters HL Cohen LF et al. Effects of 8-methoxypsoralen and ultraviolet radiation on human lymphoid cells in vitro J Invest Dermatol 1981 76 80 7
50. Berger CL Cantor C Welsh J et al. Comparison of synthetic psoralen derivatives and 8-MOP in the inhibition of lymphocyte proliferation Ann NY Acad Sci 1985 453 80 90
51. Child FJ Ratnavel R Watkins P et al. Extracorporeal photopheresis (ECP) in the treatment of chronic graft-versus-host disease (GVHD) Bone Marrow Transplant 1999 23 881 7
52. Schooneman F Claise C Treatment of graft versus host disease (GVHD) by photopheresis? Transfus Sci 1996 17 527 36
53. Dall'Amico R Rossetti F Zulian F et al. Photopheresis in paediatric patients with drug-resistant chronic graft-versus-host disease Br J Haematol 1997 97 848 54
54. Dippel E Goerdt S Orfanos CE Long-term extracorporeal photoimmunotherapy for treatment of chronic cutaneous graft-versus-host disease: observations in four patients Dermatology 1999 198 370 4
55. Russell-Jones R Extracorporeal photopheresis in cutaneous T-cell lymphoma: inconsistent data underline the need for randomized studies Br J Dermatol 2000 142 16 21
56. Heald PW Perez MI Christensen I et al. Photopheresis therapy of cutaneous T-cell lymphoma: the Yale-New Haven Hospital experience Yale Biol Med 1989 62 629 38
57. + ratio and rapidity of response are predictors of outcome in the treatment of CTCL with extracorporeal photochemotherapy (ECP) Photodermatol Photoimmunol Photomed 1996 12 36 (Abstr.).
58. Koh HK Davis BE Meola T et al. Extracorporeal photopheresis for the treatment of 34 patients with cutaneous T-cell lymphoma (CTCL) J Invest Dermatol 1994 102 567 (Abstr.).
59. Gottlieb SL Wolfe JT Fox FE et al. Treatment of cutaneous T-cell lymphoma with extracorporeal photopheresis monotherapy and in combination with recombinant interferon alfa: a 10-year experience at a single institution J Am Acad Dermatol 1996 35 946 57
60. Prinz B Behrens W Holzle E Plewig G Extracorporeal photopheresis for the treatment of cutaneous T-cell lymphoma - the Dusseldorf and Munich experience Arch Dermatol Res 1995 287 621 6
61. Duvic M Hester JP Lemak A Photopheresis therapy for cutaneous T-cell lymphoma J Am Acad Dermatol 1996 35 573 9
62. Zic J Stricklin G Greer J et al. Long term follow-up of patients with cutaneous T-cell lymphoma treated with extracorporeal photochemotherapy J Am Acad Dermatol 1996 35 935 45
63. Russell-Jones R Fraser-Andrews EA Spittle M Whittaker S Extracorporeal photopheresis in Sézary syndrome Lancet 1997 350 886 (Letter).
64. Konstantinow A Balda BR Treatment of cutaneous T-cell lymphoma with extracorporeal photochemotherapy J Eur Acad Dermatol Venereol 1997 9 111 17
65. Vonderheid EC Zhang Q Lessin SR et al. Use of soluble interleukin-2 receptor levels to monitor the progression of cutaneous T-cell lymphoma J Am Acad Dermatol 1998 38 207 20
66. Jiang SB Dietz SB Kim M Lim HW Extracorporeal photochemotherapy for cutaneous T-cell lymphoma: a 9.7-year experience Photodermatol Photoimmunol Photomed 1999 15 161 5
67. Crovetti G Carabelli A Berti E et al. Photopheresis in cutaneous T-cell lymphoma: five year experience Int J Artif Organs 2000 23 55 62
68. Zouboulis CC Schmuth M Doepfmer S et al. Extracorporeal photopheresis of cutaneous T-cell lymphoma is associated with reduction of peripheral CD4+ T lymphocytes Dermatology 1998 196 305 8
69. Knobler RM Girardi M Extracorporeal photochemoimmunotherapy in cutaneous T cell lymphomas Ann NY Acad Sci 2001 941 123 38
70. Evans AV Wood BP Scarisbrick JJ et al. Extracorporeal photopheresis in Sézary syndrome: hematologic parameters as predictors of response Blood 2001 98 1298 301
71. Heald PW Rook A Perez MI et al. Treatment of erythrodermic cutaneous T-cell lymphoma with extracorporeal photochemotherapy J Am Acad Dermatol 1992 27 427 33
72. Fraser-Andrews EA Russell-Jones R Woolford AJ et al. Diagnostic and prognostic importance of T-cell receptor gene analysis in patients with Sézary syndrome Cancer 2001 92 1745 52
73. Scarisbrick JJ Whittaker S Evans AV et al. Prognostic significance of tumour burden in the blood of patients with erythrodermic primary cutaneous T-cell lymphoma Blood 2001 97 624 30
74. Kim YH Varghese A Hoppe RT Prognostic factors in erythrodermic mycosis fungoides and the Sézary syndrome Arch Dermatol 1995 131 1003 8
75. Fraser-Andrews EA Seed P Whittaker S Russell-Jones R Extracorporeal photopheresis in Sézary syndrome: no significant effect in the survival of 44 patients with a peripheral blood T-cell clone Arch Dermatol 1998 134 1001 5
76. Armus S Keyes B Cahill C et al. Photopheresis for the treatment of cutaneous T-cell lymphoma J Am Acad Dermatol 1990 23 898 902
77. Rubegni P De Aloe G Fimiani M Extracorporeal photochemotherapy in long-term treatment of early stage cutaneous T-cell lymphoma Br J Dermatol 2000 143 894 6
78. Fimiani M Rubegni P D'Ascenzo G Andreassi L Extracorporeal photochemotherapy in the early treatment of cutaneous T-cell lymphoma J Am Acad Dermatol 1994 31 828 9
79. Child FJ Mitchell TJ Whittaker SJ et al. A randomised cross-over study to compare PUVA and extracorporeal photopheresis (ECP) in the treatment of plaque stage (T2) mycosis fungoides Br J Dermatol 2001 155 Suppl. 59 16 (Abstr.).
80. Dippel E Schrag ED Goerdt S Orfanos CE Extracorporeal photopheresis and interferon-α in advanced cutaneous T-cell lymphoma Lancet 1997 350 32 3
81. Bisaccia E Gonzalez J Palangio M et al. Extracorporeal photochemotherapy alone or with adjuvant therapy in the treatment of cutaneous T-cell lymphoma: a 9-year retropective study in a single institution J Am Acad Dermatol 2000 43 263 71
82. Wollina U Looks A Meyer J et al. Treatment of stage II cutaneous T-cell lymphoma with interferon alfa-2a and extracorporeal photochemotherapy: a prospective controlled trial J Am Acad Dermatol 2001 44 253 60
83. Haley HR Davis DA Sams WM Durable loss of a malignant T-cell clone in a stage IV cutaneous T-cell lymphoma patient treated with high-dose interferon J Am Acad Dermatol 1999 41 880 3
84. Yoo EK Cassin M Lessin SR Rook AH Complete molecular remission during biologic responseq2 modifier therapy for Sézary syndrome is associated with enhanced helper T type 1 cytokine production and natural killer cell activity J Am Acad Dermatol 2001 45 208 16
85. Wilson LD Jones GW Kim D et al. Experience with total skin electron beam therapy in combination with extracorporeal photopheresis in the management of patients with erythrodermic (T4) mycosis fungoides J Am Acad Dermatol 2000 43 54 60
86. Duvic M Hymes K Heald PW et al. Bexarotene is effective and safe for treatment of refractory advanced-stage cutaneous T-cell lymphoma: multinational phase II-III trial results J Clin Oncol 2001 19 2456 71
87. Owsianowski M Gollnick H Siegert W et al. Successful treatment of chronic graft-versus-host disease with extracorporeal photopheresis Bone Marrow Transplant 1994 14 845 8
88. Rossetti D Dall'Amico R Crovetti G et al. Extracorporeal photochemotherapy for the treatment of graft-versus-host disease Bone Marrow Transplant 1996 18 175 81
89. Besnier DP Chabannes D Mahe B et al. Treatment of graft-versus-host disease by extracorporeal photochemotherapy: a pilot study Transplantation 1997 64 49 54
90. Greinix HT Volc-Platzer B Rabitsch W et al. Successful use of extracorporeal photochemotherapy in the treatment of severe acute and chronic graft-versus-host disease Blood 1998 92 3098 104
91. Balda BR Konstantinow A Starz H et al. Extracorporeal photochemotherapy as an effective treatment modality in chronic graft-versus-host disease J Eur Acad Dermatol Venereol 1996 7 155 62
92. Bolwell B Fishleder A Lichtin A et al. Photopheresis for the treatment of chronic GVHD Blood 1998 92 Suppl. 1 529a (Abstr.).
93. Bloom E Telang G Jegasothy Bq4 Extracorporeal chemophotopheresis (ECPP) in treatment of chronic GvHD after allogeneic bone marrow transplantation (allo BMT) ASCO Proc 1991 (Abstr.).
94. Crovetti G Carabelli A Bertani E et al. Case report: chronic GVHD treated with extracorporeal photochemotherapy (ECP). In: World Apheresis Association - 6th International Congress Florence, Italy 1996 (Abstr. 046).
95. ® sterile solution Blood 1998 92 10 Suppl. 1 454a (Abstr.).
96. Taylor PC Extracorporeal photopheresis in the treatment of chronic graft versus host disease. In: European Group for Blood and Marrow Transplantation Annual Meeting 2000 (Abstr. 460).
97. Alcindor T Miller K Sprague K et al. Decreased number of dendritic cells after photopheresis in patients with chronic graft-vs-host disease ASCO Proc 2000 41 520 (Abstr.).
98. Martinez C Martino R Carnicer M et al. Extracorporeal photochemotherapy (ECP) in chronic graft-versus-host disease. Initial experience Blood 2000 96 11 Suppl. 1 5255 (Abstr.).
99. Shechter Y Haddad N Oliven A et al. Photopheresis in chronic GvHD: a single center experience Blood 2000 96 11 Suppl. 1 5260 (Abstr.).
100. Apisarnthanarax N Duvic M Donato M et al. ECP in the management of steroid refractory (SR) or steroid dependent (SD) extensive cutaneous chronic GVHD after allogenic stem cell transplantation (ASCT): feasibility and results Blood 2001 98 11 Suppl. 1 1675 (Abstr.).
101. Messina C Locatelli F Lanino E et al. Graft versus host disease and extracorporeal photochemotherapy: a multicenter retrospective paediatric study Blood 2001 98 11 Suppl. 1 3088 (Abstr.).
102. Lazarus HM Vogelsan GB Rowe JM Prevention and treatment of acute graft-versus-host disease: the old and the new. A report from The Eastern Cooperative Oncology Group (ECOG) Bone Marrow Transplant 1997 19 577 600
103. Looks A Fuchs D Rulke D et al. Successful treatment of acute graft-versus-host disease after allogeneic bone marrow transplantation in a 16-year-old girl with extracorporeal photopheresis Onkologie 1997 20 340 2
104. Richter HI Stege H Ruzicka T et al. Extracorporeal photopheresis in the treatment of acute graft-versus-host disease J Am Acad Dermatol 1997 36 787 9
105. Grenix HT Volc-Platzer B Kalhs P et al. Extracorporeal photochemotherapy in the treatment of severe steroid-refractory acute graft-versus-host disease: a pilot study Blood 2000 96 2426 31
106. Billingham ME Cary NRB Hammond ME et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group J Heart Transplant 1990 9 587 93
107. Costanzo-Nordin MR Hubbell EA O'Sullivan EJ et al. Photopheresis versus corticosteroids in the therapy of heart transplant rejection: preliminary clinical report Circulation 1992 86 Suppl. 2 242 50
108. Maccherini M Ciciolla F Laghi Pasini G et al. Photopheresis immunomodulation after heart transplantation Transplant Proc 2001 33 1591 4
109. Dall'Amico R Livi U Milano A et al. Extracorporeal photochemotherapy as adjuvant treatment of heart transplant recipients with recurrent rejection Transplantation 1995 60 1 4
110. Dall'Amico R Montini G Murer L et al. Benefits of photopheresis in the treatment of heart transplant patients with multiple/refractory rejection Transplant Proc 1997 29 609 11
111. Rose EA Barr ML Xu H et al. Photochemotherapy in human heart transplant recipients at high risk for fatal rejection J Heart Lung Transplant 1992 11 746 50
112. Meiser BM Kur F Reichenspurner H et al. Reduction of the incidence of rejection by adjunct immunosuppression with photochemotherapy after heart transplantation Transplantation 1994 57 563 8
113. Barr ML Baker CJ Schenkel FA et al. Prophylactic photopheresis and chronic rejection: effects on graft intimal hyperplasia in cardiac transplantation Clin Transplant 2000 14 162 6
114. Sunder-Plassman G Druml W Steininger R et al. Renal allograft rejection controlled by photopheresis Lancet 1995 346 506
115. Dall'Amico R Murer L Montini G et al. Successful treatment of recurrent rejection in renal transplant patients with photopheresis J Am Soc Nephrol 1998 9 121 7
116. Wolfe JT Tomaszewski JE Grossman RA et al. Reversal of acute renal allograft rejection by extracorporeal photopheresis: a case presentation and review of the literature J Clin Apheresis 1996 11 36 41
117. Baron ED Heeger PS Hricik DE et al. Immunomodulatory effect of extracorporeal photopheresis after successful treatment of resistant renal allograft rejection Photodermatol Photoimmunol Photomed 2001 17 79 82
118. Cooper JD Billingham M Egan T et al. A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. International Society for Heart and Lung Transplantation J Heart Lung Transplant 1993 12 713 16
119. Slovis BS Loyd JE King LE Jr. Photopheresis for chronic rejection of lung allografts N Engl J Med 1995 332 962
120. Salerno CT Park SJ Kreykes NS et al. Adjuvant treatment of refractory lung transplant rejection with extracorporeal photopheresis J Thorac Cardiovasc Surg 1999 117 1063 9
121. Villanueva J Bhorade SM Robinson JA et al. Extracorporeal photopheresis for the treatment of lung allograft rejection Ann Transplant 2000 5 44 7
122. Andreu G Achkar A Couetil JP et al. Extracorporeal photochemotherapy treatment for acute lung rejection episode J Heart Lung Transplant 1995 14 793 6
123. Achkar A Laaban JP Andreu G et al. Extracorporeal photochemotherapy for bronchiolitis obliterans Am J Respir Crit Care Med 1991 1 A2777 (Abstr.).
124. O'Hagan AR Stillwell PC Arroliga A Koo A Photopheresis in the treatment of refractory bronchiolitis obliterans complicating lung transplantation Chest 1999 115 1459 62
125. DiSpaltro FX Cottril C Cahill C et al. Extracorporeal photochemotherapy in progressive systemic sclerosis Int J Dermatol 1993 32 417 20
126. Schwartz J Gonzalez J Palangio M et al. Extracorporeal photochemotherapy in progressive systemic sclerosis: a follow-up study Int J Dermatol 1997 36 380 5
127. Krasagakis K Dippel E Ramaker J et al. Management of severe scleroderma with long-term extracorporeal photopheresis Dermatology 1998 196 309 15
128. Zachariae H Bjerring P Heickendorff L et al. Photopheresis in systemic sclerosis: clinical and serological studies using markers of collagen metabolism Acta Derm Venereol (Stockh) 1993 73 356 61
129. Cribier B Faradji T Le Coz C et al. Extracorporeal photochemotherapy in systemic sclerosis and severe morphea Dermatology 1995 191 25 31
130. Enomoto DNH Mekkes JR Bossuyt PMM et al. Treatment of patients with systemic sclerosis with extracorporeal photochemotherapy (photopheresis) J Am Acad Dermatol 1999 41 915 22
131. Khavani PA Edelson RL Lider Ö et al. Specific vaccination against photoactivated cloned T-cells Clin Res 1988 36 662A
132. Pochlau D Rieks M Postert T et al. Photopheresis - a possible treatment of multiple sclerosis? Report of two cases J Clin Apheresis 1997 12 154 5
133. Hilliquin P Andreu G Heshmati F Menkes CJ Treatment of refractory rheumatoid polyarthritis by extracorporeal photochemotherapy Rev Rhum 1993 60 125 30
134. Vonderheid EC Kang CA Kadin M et al. Extracorporeal photopheresis in psoriasis vulgaris: clinical and immunologic observations J Am Acad Dermatol 1990 23 703 12
135. De Misa RF Azaña JM Harto A et al. Psoriatic arthritis: one year treatment with extracorporeal photochemotherapy J Am Acad Dermatol 1994 30 1037 8
136. Vahlquist C Larsson M Ernerudh J et al. Treatment of psoriatic arthritis with extracorporeal photochemotherapy and conventional psoralen-ultraviolet A irradiation Arthritis Rheum 1996 39 1519 23
137. Miller JL Stricklin GP Fine JD et al. Remission of severe epidermolysis bullosa acquisita induced by extracorporeal photochemotherapy Br J Dermatol 1995 133 467 71
138. Gordon KB Chan LS Woodley DT Treatment of refractory epidermolysis bullosa acquisita with extracorporeal photochemotherapy Br J Dermatol 1997 136 415 20
139. Camara A Bécherel PA Bussel A et al. Resistant acquired bullous epidermolysis with severe ocular involvement: the success of extracorporeal photochemotherapy Ann Dermatol Venereol 1999 126 612 15
140. Engineer L Ahmed AR Emerging treatment for epidermolysis bullosa acquisita J Am Acad Dermatol 2001 44 818 28
141. Rook AH Jegasothy BV Heald PW et al. Extracorporeal photochemotherapy for drug-resistant pemphigus vulgaris Ann Intern Med 1990 112 303 5
142. Gollnick HPM Owsianowski M Taube KM Orfanos CE Unresponsive severe generalised pemphigus vulgaris successfully controlled by extracorporeal photopheresis J Am Acad Dermatol 1993 28 122 4
143. Mohla G Horvath N Stevens S Quality of life improvement in a patient with severe atopic dermatitis treated with photopheresis J Am Acad Dermatol 1999 40 780 2
144. Richter HI Billmann-Eberwein C Grewe M et al. Successful monotherapy of severe and intractable atopic dermatitis by photopheresis J Am Acad Dermatol 1998 38 585 8
145. Bisaccia E Berger C DiSpaltro FX Klainer AS Extracorporeal photopheresis in the treatment of AIDS-related complex: extended trial J Acquir Immune Defic Syndr 1993 6 386 92
146. Gonzalez J Berger C Cottrill CM et al. Cytolytic response to HIV in patients with HIV disease treated with extracorporeal photochemotherapy: preliminary study Photochem Photobiol 1996 63 558 61
147. D'Incan M Franck F Kanold J et al. Cutaneo-systemic papulosclerotic mucinosis (scleromyxedema): remission after extracorporeal photochemotherapy and corticoid bolus Ann Dermatol Venereol 2001 128 38 41
148. Krasagakis K Zouboulis CC Owsianowski M et al. Remission of scleromyxoedema following treatment with extracorporeal photopheresis Br J Dermatol 1996 135 463 6
149. Dean FA Caring for CTCL patients undergoing photopheresis Dermatol Nurs 1990 2 26 8